Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 0 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
FEBELCOFONDS from Sint-Niklaas, company number BE0479158422, closed financial year 2025 with a result of € 2.8 million after tax. Compared with financial year 2024, the result moved from € 1.2 million to € 2.8 million. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 8.7 million
▼ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2.8 million
▲ 131% vs 2024
Profit after tax over the fiscal year.
€ 3,066
▼ 41% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2.8 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 7
▼ 99% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -490 | € -5,527 | - | - | |
| Profit after taxes | € 931,262 | € 635,680 | € 1,227,815 | € 2,840,417 | ▲ 131% |
| Equity | € 10,990,069 | € 10,625,477 | € 10,011,948 | € 8,674,604 | ▼ 13% |
| Total debts | € 769,073 | € 822,933 | € 347,326 | € 1,013,520 | ▲ 192% |
| Cash | € 1,297 | € 3,303 | € 5,202 | € 3,066 | ▼ 41% |
| Retained profit | € 1,420,117 | € 1,433,669 | € 1,586,611 | € 2,840,417 | ▲ 79% |
| Balance sheet total | € 11,759,142 | € 11,448,410 | € 10,359,274 | € 9,688,124 | ▼ 6% |
Key figures of FEBELCOFONDS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to FEBELCOFONDS?
What happened at FEBELCOFONDS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Aristo BV stepped down as director. NBB
- Eric Van Nueten stepped down as director. NBB
- KST Pharma BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.8 million (▲ 131% vs 2024). filed late Source: NBB ↗
- KST Pharma BV became a director. NBB
- Aristo BV became a director. NBB
- Eric Van Nueten became a director. NBB
- New establishment in Sint-Niklaas. KBO
In short
From € 931,262 profit in 2022 to € 2.8 million profit in 2025.
Paid € 4,678 in corporate taxes since 2022.
Best year ever: 2025, with € 2.8 million profit.
Management
Directors
According to the 2025 annual accounts
Managing director · represented by Koen Straetmans
since 2026 · until 2027
Chairman of the board · represented by Frank Coene
Also active at: LIVLINA, FEBELCO, FEBELFARMA, AXONE PHARMA, LIVLINA TRANSPORT
since 2022 · until 2028
Eric Van Nueten
Director
Also active at: APOTHEEK MOLENVELD, FEBELCO, FEBELFARMA, EVN CONSULTING, E.V.N. PHARMA
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Eigenlostraat 1
9100 Sint-Niklaas
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0479.158.422
- VAT number
- BE 0479.158.422
- Registered office
- Eigenlostraat 1, 9100 Sint-Niklaas
- Names & denominations
- FEBELCOFONDS
- Enterprise type
- Rechtspersoon
- Legal form
- Cooperative company
- Legal situation
- Normale toestand
- Start date
- 27 December 2002
- Peppol
- Active · Active since 23 Dec 2025
- Contact
- [email protected]